Drugs / PARPi-FL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03631017 | Aug 2018 → Aug 2026 overdue | head and neck cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PARPi-FL | “The purpose of this study is to test the safety of a study drug called PARPi-FL.” NCT03631017 ↗ |